Investigative teams at Universitá Degli Studi di Torino (UNITO), Ruprecht Karls-Universitaet Heidelberg (UHEI) and RCSI, the Royal College of Surgeons in Ireland have recently published two COLOSSUS-acknowledged studies. Congratulations to all researchers involved!
The first study by Irene Catalano and Livio Trusolino at UNITO, The Stromal and Immune Landscape of Colorectal Cancer Progression during Anti-EGFR Therapy was published in the July 8, 2019 edition of Cancer Cell, Volume 36, Issue 1, 8 July 2019, Pages 1-3, DOI: 10.1016/j.ccell.2019.06.001.
The second study, Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A by Elke Burgermeister, Francesca Battaglin, Fagr Eladly, Wen Wu, Frank Herweck , Nadine Schulte, Johannes Betge, Nicolai Härtel, Jakob N. Kather, Cleo-Aron Weis, Timo Gaiser, Alexander Marx, Christel Weiss, Ralf Hofheinz, Ian S. Miller, Fotios Loupakis, Heinz-Josef Lenz, Annette T. Byrne, Matthias P. Ebert appeared in the July 9, 2019 issue of EBioMedicine; 45:139-154. DOI: 10.1016/j.ebiom.2019.07.004.
See the whole list of COLOSSUS publications here.